Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for shoulder pain in myofascial pain syndrome with central sensitization after arthroscopic rotator cuff repair
KCT0009403Phase 4Not yet recruiting
- Sponsor
- Viatris
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in rotator cuff tear, chronic myofascial pain (CMP), Central sensitization (CS), sponsored by Viatris. Planned start May 2024; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
rotator cuff tearchronic myofascial pain (CMP)Central sensitization (CS)
Beyond the preview
Go deeper on KCT0009403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009403.